Crossmark

Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease

Crossref DOI link: https://doi.org/10.1186/s12886-015-0001-7

Published Online: 2015-03-08

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Menke, Marcel N

Framme, Carsten

Nelle, Mathias

Berger, Markus R

Sturm, Veit

Wolf, Sebastian
License Information

License valid from 2015-03-08
More Information

Article History

Received: 6 May 2014

Accepted: 29 January 2015

First Online: 8 March 2015